Literature DB >> 15961819

Aspirin for everyone older than 50? Against.

Colin Baigent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15961819      PMCID： PMC558386          DOI： 10.1136/bmj.330.7505.1442

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies.

Authors:  Sonia Hernández-Díaz; Luis Alberto García Rodríguez
Journal:  J Clin Epidemiol       Date:  2002-02       Impact factor: 6.437

2.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1984-09       Impact factor: 3.710

3.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

Authors:  G de Gaetano
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

4.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

5.  Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors: 
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

6.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors:  P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

7.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

9.  Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).

Authors:  Mark Nelson; Christopher Reid; Lawrence Beilin; Geoffrey Donnan; Colin Johnston; Henry Krum; Elsdon Storey; Andrew Tonkin; John McNeil
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more
  6 in total

1.  [Acetylsalicylic acid protects against solid tumors].

Authors:  J R Izbicki; B T Hofmann; S Nitschmann
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

2.  Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan.

Authors:  Choitsu Sakamoto; Kentaro Sugano; Shinichi Ota; Nobuhiro Sakaki; Shin'ichi Takahashi; Yukio Yoshida; Taku Tsukui; Hiroyuki Osawa; Yukihiro Sakurai; Junji Yoshino; Yuji Mizokami; Tetsuya Mine; Tetsuo Arakawa; Hajime Kuwayama; Katsunori Saigenji; Koji Yakabi; Tsutomu Chiba; Tooru Shimosegawa; Jane E Sheehan; Susana Perez-Gutthann; Takuhiro Yamaguchi; David W Kaufman; Tsugumichi Sato; Kiyoshi Kubota; Akira Terano
Journal:  Eur J Clin Pharmacol       Date:  2006-07-04       Impact factor: 2.953

3.  Aspirin for everyone over 50? Don't forget aspirin resistance.

Authors:  Ketan K Dhatariya
Journal:  BMJ       Date:  2005-07-16

4.  Potential contribution of aspirin to cancer control programmes.

Authors:  G Morgan
Journal:  Ecancermedicalscience       Date:  2008-11-12

5.  Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk.

Authors:  Peter C Elwood; Gareth Morgan; Julieta Galante; John W K Chia; Sunil Dolwani; J Michael Graziano; Mark Kelson; Angel Lanas; Marcus Longley; Ceri J Phillips; Janet Pickering; Stephen E Roberts; Swee S Soon; Will Steward; Delyth Morris; Alison L Weightman
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

6.  Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.

Authors:  Hideki Ishikawa; Keiji Wakabayashi; Sadao Suzuki; Michihiro Mutoh; Keiji Hirata; Tomiyo Nakamura; Ikuko Takeyama; Atsuko Kawano; Nobuhisa Gondo; Takashi Abe; Shinkan Tokudome; Chiho Goto; Nariaki Matsuura; Toshiyuki Sakai
Journal:  Cancer Med       Date:  2013-02-03       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.